Celgene Corporation (CELG) financial statements (2020 and earlier)

Company profile

Business Address 86 MORRIS AVENUE
SUMMIT, NJ 07901
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 4,73012,0427,9706,5527,5475,687
Cash and cash equivalents 4,2347,0136,1704,8804,1223,234
Short-term investments 4965,0291,8001,6723,4252,453
Receivables 2,0661,9211,6211,4211,1671,061
Inventory, net of allowances, customer advances and progress billings 458541498443393340
Inventory 458541498443393340
Other current assets 501388779985594436
Other undisclosed current assets 1,312   1225
Total current assets: 9,06714,89210,8689,4019,7137,551
Noncurrent Assets
Property, plant and equipment 1,3671,070930814643593
Intangible assets, net (including goodwill) 24,21613,30215,25815,7376,2594,881
Goodwill 8,0034,8664,8664,8792,1912,041
Intangible assets, net (excluding goodwill) 16,2138,43610,39210,8584,0682,840
Other noncurrent assets 8308771,0311,101726353
Total noncurrent assets: 26,41315,24917,21817,6537,6285,828
TOTAL ASSETS: 35,48030,14128,08627,05317,34013,378
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 2,9872,5232,1151,6181,4841,427
Accounts payable 418305247241198156
Accrued liabilities 2,9872,5232,1151,3779911,001
Employee-related liabilities     285262
Taxes payable     98
Other undisclosed accounts payable and accrued liabilities (418)(305)(247)   
Debt 50135501 606545
Derivative instruments and hedges, liabilities    5356
Estimated litigation liability   199   
Deferred revenue and credits7555612928
Deferred tax liabilities    131 
Contract with customer, liability73
Other liabilities    271276200
Other undisclosed current liabilities 4963549015(416)(309)
Total current liabilities: 4,0572,9872,9591,9692,1121,946
Noncurrent Liabilities
Long-term debt and lease obligation 19,76915,83813,78914,2506,26614
Long-term debt, excluding current maturities 19,76915,83813,78914,2506,26614
Liabilities, other than long-term debt 5,4934,3952,2193,3222,6231,802
Deferred revenue and credits3428305952
Accounts payable and accrued liabilities 2,1902,490420324  
Accrued income taxes273235
Contract with customer, liability73
Deferred compensation liability, classified    171151127
Deferred tax liabilities, net2,7531,327 378556805
Other liabilities 4775441,7712,0421,581583
Derivative instruments and hedges, liabilities    3784 
Other undisclosed noncurrent liabilities   2,5191,593(186)4,027
Total noncurrent liabilities: 25,26220,23318,52719,1668,7035,843
Total liabilities: 29,31923,22021,48621,13410,8157,788
Stockholders' equity
Stockholders' equity attributable to parent 6,1616,9216,5995,9196,5255,590
Common stock 101010995
Treasury stock, value (26,336)(20,243)(16,281)(14,052)(10,699)(7,662)
Additional paid in capital 14,97813,80612,37811,1199,8278,680
Accumulated other comprehensive income (loss) (50)28741976891594
Retained earnings 17,55913,06110,0748,0746,4724,473
Other undisclosed stockholders' equity (6,211)(6,634)(6,180)   
Total stockholders' equity: (50)2874195,9196,5255,590
Other undisclosed liabilities and equity 6,2116,6346,180   
TOTAL LIABILITIES AND EQUITY: 35,48030,14128,08627,05317,34013,378

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 15,28113,00311,2299,2567,6706,494
Revenue, net13,00311,2299,2567,6706,494
Cost of revenue (1,055)(790)(897)(699)(386)(340)
Cost of goods and services sold (587)(461)(438)(420)(386)(340)
Other undisclosed gross profit 452299414184(107)(132)
Gross profit: 14,67812,51210,7478,7417,1786,022
Operating expenses (9,035)(7,506)(7,166)(6,302)(4,904)(4,464)
Other undisclosed operating income (loss) (452)(299)(414)(184)245251
Operating income: 5,1914,7073,1672,2552,5191,809
Nonoperating income (expense) 382105(294)80(25)(74)
Investment income, nonoperating 4510530312822
Foreign currency transaction loss, before tax     (10)(22)
Other nonoperating income (expense) 337 (324)48(44)(74)
Interest and debt expense (741) (500)(311)(176)(92)
Income from continuing operations before equity method investments, income taxes: 4,8324,8122,3732,0242,3181,643
Other undisclosed income (loss) from continuing operations before income taxes  (498)  1022
Income from continuing operations before income taxes: 4,8324,3142,3732,0242,3271,665
Income tax expense (786)(1,374)(373)(422)(328)(216)
Net income available to common stockholders, diluted: 4,0462,9401,9991,6022,0001,450

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income: 4,0462,9401,9991,6022,0001,450
Other comprehensive income (loss) 233(102)(349)(147)821144
Comprehensive income, net of tax, attributable to parent: 4,2792,8381,6511,4552,8211,594

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: